In adults with type 2 diabetes and nephrotic-range proteinuria, SGLT2 inhibitors are linked to lower risks for major adverse kidney events and all-cause mortality than DPP-4 inhibitors.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/sglt2-inhibitors-cut-kidney-events-nephrotic-proteinuria-2026a1000ifu?src=rss
Author :
Publish date : 2026-06-03 10:27:00
Copyright for syndicated content belongs to the linked Source.